Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,957 public trials 633 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin

NCT04387461

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +14 more
Locations
  • University of California - San Diego La Jolla, California, United States
  • University of California - Irvine Orange, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Tampa, Florida, United States
View all 19 locations
View Trial Details
Completed

Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

NCT03532451

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT05136898

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
Locations
  • Urology Centers of Alabama (UCA) Homewood, Alabama, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • Medication Management Greensboro, North Carolina, United States
  • Urology Associates, P.C. Nashville, Tennessee, United States
View Trial Details

Related conditions